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ABSTRACT 
The purpose of this study was to investigate the effects of BCAA supplementation on 
muscle recovery from resistance exercise (RE) in untrained young adults. Twenty-four 
young adults (24.0 ± 4.3 years old) were assigned to 1 of 2 groups (n = 12 per group): a 
placebo-supplement group or an BCAA-supplement group. The groups were 
supplemented for a period of 5 days. On day 1 and 3, both groups underwent a RE 
session involving two lower body exercises (hack squat and leg press) and then were 
evaluated for muscle recovery on the 3 subsequent moments after the RE session (30 
min. [day 3], 24 h [day 4], and 48 h [day 5]). The following indicators of muscle 
recovery were assessed: number of repetitions, rating of perceived exertion in the last 
RE session, muscle soreness and countermovement jump (CMJ) during recovery period 
(30 min., 24 h, and 48 h after RE session). Number of repetitions remained unchanged 
over time (time, P > 0.05), while the rating of perceived exertion increased (time, P < 
0.05) over 3 sets, with no difference between groups (group x time, P > 0.05). Muscle 
soreness increased (time, P < 0.05) and jumping weight decreased (time, P < 0.05) at 30 
min. postexercise and then progressively returned to baseline at 24 and 48 h 
postexercise, with no difference between groups (group x time, P > 0.05). The results 
indicate that BCAA supplementation does not improve muscle recovery from RE in 
untrained young adults. 
keywords: supplementation; essential amino acids; muscle function; strength exercise; 
muscle soreness; muscle power. 
 
 
INTRODUCTION 
 Protein and amino acids supplements are frequently consumed by athletes and 
recreationally-active adults to improve physical performance and muscle recovery. In 
particular, the branched-chain amino acids (BCAA) family, leucine, isoleucine and 
valine, has received special attention in the last 35 years because of their supposed 
effects on muscle protein synthesis (Wolfe et al. 2017). BCAA are three of the nine 
essential amino acids (EAAs) that comprise muscle (14-18% of the total EAAs) and 
body (35-40% of the total EAAs) proteins (Riazi et al. 2003; Layman and Baum, 2004; 
Shimomura et al. 2006), and along with the eleven non-essential amino acids (NEAAs) 
are responsible for the synthesis of new muscle protein (Wolfe et al. 2017).  
 BCAA, especially leucine, has been shown to enhance muscle protein synthesis 
and reduce breakdown after exercise by stimulating the phosphorylation of anabolic 
factors (i.e., mammalian target of rapamycin [mTOR] and 70-kDa S6 protein kinase 
[p70s6k] (Karlsson et al., 2004; Blomstrand et al. 2006; Jackman et al. 2017) and 
reducing gene expression of catabolic factors, such as muscle RING-finger 1 (MuRF-1) 
and muscle atrophy F-box (MAFbx) (Borgenvik et al. 2012). Despite this supposed 
anabolic propriety, the effects of BCAA supplementation on markers of muscle 
recovery remains controversial. While several studies have shown beneficial effects on 
muscle soreness (Jackman et al. 2010; Shimomura et al. 2006; Shimomura et al. 2010; 
Howatson et al. 2012; Kim et al. 2013; Greer et al. 2007), muscle strength (Shimomura 
et al. 2010; Howatson et al. 2012; Greer et al. 2007) and creatine kinase (CK) activity 
(Howatson et al. 2012; Sharp and Pearson, 2010; Nosaka et al. 2006), others have not 
(Knechtle et al. 2012; Ra et al. 2013; Areces et al. 2014; Pasiakos et al. 2014; Fouré et 
al. 2016).  
 
 
The explanation for these conflicting results remains unknown but may be 
related to differences in the study designs (e.g., dosage, period, and supplementation 
timing), subjects’ training status, and the large interindividual variability in levels of 
indirect markers of muscle damage (e.g., CK). Another recurring limitation in several 
studies is the lack of dietary monitoring, mainly in relation to dietary protein intake, 
which may markedly confound the interpretation of the results. Moreover, it is 
important to mention that most of the studies involving BCAA supplementation on 
recovery markers have reported a mix of muscle damage (i.e., from low-to-high) and 
exercise types (i.e., eccentric exercise, drop jumps, strength exercises, running, and 
cycling ergometer) (for a review see Fouré and Bendahan, 2017), making it difficult to 
establish a consensus on the ergogenic effects of BCAA during recovery process. 
Therefore, well-controlled studies are warranted to confirm whether supplementation of 
BCAA could alleviate the alterations of muscle soreness and function during time 
course of recovery from exercise, mainly in response to a conventional resistance 
exercise (RE) session. 
The purpose of this study was to investigate the effects of BCAA 
supplementation on muscle recovery from RE in untrained young adults. Considering 
previous positive findings on muscle anabolism following exercise (Karlsson et al., 
2004; Blomstrand et al. 2006; Jackman et al. 2017), we hypothesized that BCAA 
supplementation would ameliorate the negative symptoms associated with high-
intensity RE stimulus, including muscle soreness and loss of muscle function (i.e., 
number of maximum repetitions, and jumping power output), when compared with the 
placebo. 
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METHODS 
Participants 
Twenty-four healthy individuals were recruited from a university population, and all 
completed the study. Descriptive characteristics of the participants are presented in 
Table 1. An a priori power analysis was conducted (G*Power version 3.0.1) for an F 
test (repeated measures, within-between interaction factors for 4 time points). On the 
basis of a statistical power (1 – β) of 0.90, a moderate effect size (0.5), and an overall 
level of significance of 0.05, at least 10 participants were required in each group. 
Participants were included if they (i) had not ingested any ergogenic supplement or 
anabolic steroid during the 6 months prior to the start of the study, (ii) were not taking 
any medication that could affect muscle recovery or the ability to train intensely, (iii) 
had not participated in a exercise training program for more than 2 days per week 
during the 6 months prior to the beginning of the study, (iv) were able to provide a 
detailed description of their lifestyle and daily food intake, or (v) did not have medical 
approval to perform physical exercise. All participants were informed of the procedures, 
risks, and benefits of the investigation and signed an informed consent document 
approved by the Institutional Review Board of the University (protocol #1.748.002). All 
procedures were carried out in accordance with the ethical standards as laid down in the 
1964 Declaration of Helsinki and its later amendments or comparable ethical standards. 
Experimental design 
A double-blind, placebo-controlled, parallel-groups design with repeated measures was 
performed to examine the effects of BCAA supplementation on the time course of 
muscle recovery from RE in young adults (Fig. 1). Initially, all participants completed 3 
sessions of tests of 10-repetition maximum (10RM) for leg press and hack squat 
exercises, following 2 familiarization sessions with countermovement jump (CMJ) test, 
 
 
OMNI-RES scale (rating of perceived exertion), visual analogic scale (VAS, muscle 
soreness), and exercises (leg press and hack squat) in order to minimize any potential 
learning effect. Thereafter, the participants were matched according to sex and 10RM 
strength and then randomly assigned to a BCAA or placebo group (N = 12 per group; 9 
men and 3 women in each group), who were supplemented for a period of 5 days. On 
day 1 and 3, both groups underwent a session of RE and then evaluated for muscle 
recovery on the 3 subsequent moments (30 min. [day 3], 24 h [day 4], and 48 h [day 5]) 
after the RE session. The following indicators of muscle recovery were assessed: 
number of repetitions and rating of perceived exertion in the last RE session (day 3), 
and muscle soreness and countermovement jump (CMJ) during recovery period (30 
min., 24 h, and 48 h after last RE session). Moreover, all participants completed a 3-day 
dietary intake record between RE sessions (days 1-3) to monitor any influence of diet. 
** Figure 1 about here ** 
Determination of 10RM load 
Before randomization, all participants completed 3 sessions of leg press and hack squat 
10RM tests, using standard protocols previously documented elsewhere (da Silva et al. 
2017; Andrade et al. 2018). The test was preceded by a warm-up exercise (~15 
repetitions) at approximately 50% of the load to be used in the first attempt of the test. 
After 2 min of rest, the attempts were performed with a progressively increasing load 
(5%–10%) for each attempt and were separated by 4- to 5-min rest intervals to allow 
adequate recovery. Only 3 attempts were allowed in each testing session, and verbal 
encouragement was provided during each attempt. The exercises were standardized and 
continuously monitored by the same experienced rater in an attempt to ensure data 
quality and determine the load within 3 attempts. The intraclass correlation coefficient 
for test–retest reliability was ≥0.93 for 10RM (da Silva et al. 2017) tests, respectively, 
 
 
indicating the elimination of the learning curve for the participants. All tests sessions 
were performed at the same location between 8:00 and 10:00 am. 
Resistance exercise session 
On days 1 and 3 of supplementation, both groups underwent a session of RE involving 
the hack squat and leg press exercises (3 sets at 80% of 10RM) (Nakagym equipment, 
São Paulo, Brazil), with 2 min of rest between sets and exercises. A set was completed 
when reaching 12 repetitions or as many fewer repetitions as possible before reaching 
volitional fatigue. The cadence of muscle action was 1 s concentric: 2 s eccentric 
according to a metronome. This protocol was designed to maximize the recruitment of 
quadriceps muscle, and the training stimulus was similar to a conventional RE session 
for novice individuals (ACSM, 2009). We have chosen to use the 10RM load (as 
opposed to 1RM) due to its easy application in the practical context and safety for 
novice practitioners. RE session began with general (moderate walking on treadmill for 
10 min) and specific (12 repetitions in the leg press, with a self-selected load) warm-up 
exercises for quadriceps muscle. Qualified personnel (e.g., personal trainer and 
physiologist) supervised each participant individually during the sessions, and the 
number of repetitions was registered. The RE sessions were performed between 8:00 
and 10:00 a.m.  
Supplementation 
The groups were supplemented orally with an identical looking and equivalent amount 
of BCAA (8 g) plus 4 g maltodextrin (Arboretum®, Londrina, PR, Brazil) or 12 g of 
placebo-maltodextrin, dissolved into 300 mL of water. Maltodextrin was added to 
ensure that the drinks were indistinguishable in taste. The BCAA drink contained a 
2:1:1 ratio of leucine (4 g), isoleucine (2 g), and valine (2 g), and was consumed 
(identical to placebo group), 15 min prior to RE sessions and functional tests (days 1, 3, 
 
 
4 and 5) and at breakfast on day off (day 2). BCAA drink (or placebo) were ingested 15 
min prior to RE sessions and functional tests based on previous studies that reported (i) 
an elevation in plasma BCAA concentrations within 15 min and a peak 30 min after 
ingestion of a 5.5-g BCAA mixture (Shimomura et al., 2006), (ii) a greater postexercise 
muscle-protein synthesis when an essential amino acid–carbohydrate mixture was 
consumed before exercise, rather than after (Tipton et al., 2001), (iii) a decrease in 
muscle-protein breakdown when BCAA was consumed before exercise (MacLean et al., 
1994), and (iv) a attenuation in muscle damage and loss of strength during recovery 
when a 5.5-g BCCA mixture was consumed 15 min prior to high-intensity RE 
(Shimomura et al. 2010). Moreover, we chose to provide 8 g of BCAA because lower 
doses (2.5-5.5 g) have been shown to increase the plasma BCAA concentration 
(Shimomura et al. 2010; Fouré et al. 2016). To ensure the double-blind design, an 
individual who was not involved in the study was responsible for placing the 
supplements into bags and labeling the capsules with the subjects’ names according to 
the randomization list.  
Nutrient intake 
Participants completed a 3-day dietary intake record between RE sessions (days 1-3). 
The macronutrient composition of the diets was calculated using software for nutritional 
assessment (Avanutri version 3.1.4, Avanutri Equipamentos de Avaliação, Ltda, Rio de 
Janeiro, Brazil). Participants were instructed to duplicate their food intake for the 24 h 
preceding each session and to refrain from any strenuous activity during the 
experimental period. The participants were also instructed to report any adverse events 
from the supplements. No discomfort or adverse effects were reported after BCAA 
ingestion. 
 
 
 
Perceived exertion 
Rating of perceived exertion was measured immediately after each set of leg press 
exercise in the last RE session (day 3) using the OMNI-RES scale (Robertson et al. 
2003). The participants were instructed to report the perceived exertion value by 
indicating a number on the OMNI-RES scale (0 for “no effort” and 10 for “maximal 
effort”) that best represented their overall muscular effort (Robertson et al. 2003; 
Marcora, 2009). The score was the value (0–10) reported in OMNI-RES scale. All 
participants were familiar with the OMNI-RES scale before starting the study. 
Muscle soreness 
Muscle soreness was measured at baseline (day 0), and 30 min. (day 3), 24 h (day 4) 
and 48 h (day 5) after last RE session, using a visual analog scale (VAS). The VAS 
consisted of a 10-cm line whose endpoints were labeled with “no pain” (left) and 
“unbearable pain” (right) (Bijur et al. 2001). Participants were asked to perform two 
functional movements (walk up a flight of stairs, and walk down a flight of stairs) and 
then mark a vertical line at a scale point that best represented their rating of momentary 
soreness on quadriceps muscle (Rindom et al. 2016).  The score was the distance (in 
centimeters) from the left side of the scale to the point marked (Mattacola et al. 1997). 
The ICC of the VAS for acute soreness was ≥0.97 (Bijur et al. 2001). 
Countermovement jump  
Participants performed a CMJ on a mobile jump mat (Smart Jump, Fusion Sport, 
Australia) to assess maximal jumping height, and peak power output/body weight ratio 
(PPO/BW) (Rindom et al. 2016; Waldron et al. 2017). Participants were given three 
attempts interspaced by 1 min of recovery. The best of the three attempts was used for 
further analysis. Qualified personnel individually supervised each participant during 
 
 
test. The test re-test reliability of this procedure was 1.2% (Coefficient of variation) 
(Waldron et al. 2017) 
Statistical analysis 
Data are expressed as means ± standard deviation (SD). The normality and homogeneity 
for outcome measures were tested using Shapiro–Wilk’s and Levene’s tests, 
respectively. The independent variables included the experimental groups (i.e., Placebo 
and BCAA) and time (i.e., 30 min., 24 h, and 48 h). Dependent variables included 
number of repetitions, rating of perceived exertion, muscle soreness, jumping height, 
and PPO/BW. Baseline characteristics and nutritional intake were compared between 
groups using an unpaired t-test. Two-way (treatment x time) analysis of variance 
(ANOVA) with repeated measures was used to evaluate changes over time and between 
groups for all dependent variables. Violation of sphericity was corrected using the 
Greenhouse–Geisser method. When significant differences were confirmed with 
ANOVA, multiple comparisons testing were performed using Bonferroni post hoc 
correction to identify these differences. The significance level was set at P ≤ 0.05. 
Statistical analyses were performed using SPSS Statistics for Windows version 20.0 
(IBM Corp., Armonk, N.Y., USA). 
  
 
 
RESULTS 
Baseline characteristics and food intake. The BCAA and Placebo groups had similar 
(P > 0.05) baseline characteristics (Table 1). There were no significant (P > 0.05) 
differences between groups in daily nutritional intake during the days of training (Table 
2), and both groups had adequate macronutrient intakes according to the 
recommendations of the American College of Sports Medicine (Thomas et al. 2016). 
** Table 1 about here ** 
** Table 2 about here ** 
Number of repetitions and perceived exertion. There was no significant time effect 
(P > 0.05) or group x time interaction (P > 0.05) in number of repetitions among the 
sets (Set 1 to 3) of the leg press exercise during last RE session (Fig. 2A). There was a 
significant (time, P < 0.05) increase in perceived exertion among the 3 sets of the leg 
press (Set 1 to 3) exercise during the last RE session (Fig. 2B), with no difference 
(group x time, P > 0.05) between the groups. 
** Figure 2 about here ** 
Muscle soreness. There was no significant group x time interaction (P > 0.05), but a 
significant main effect for time (P < 0.05) indicated an increase in muscle soreness 
during walking up (Fig 3A) and down stairs (Fig. 3 B) from basal (pre-RE session) to 
30 min. postexercise, and progressively returned to baseline at 24 and 48 h post RE 
session in both groups (time, P < 0.05).  
** Figure 3 about here ** 
Countermovement jump. There was no significant group x time interaction (P > 0.05), 
but a significant main effect for time (P < 0.05) indicated a decrease in jumping height 
and PPO/BW from basal (pre-RE session) to 30 min. postexercise, and returned to 
baseline at 24 h post RE session in both groups (time, P < 0.05) (Fig. 4).  
 
 
** Figure 4 about here ** 
DISCUSSION 
The purpose of this study was to investigate the effects of BCAA supplementation on 
muscle recovery from RE in untrained young adults. Considering previous positive 
findings on muscle anabolism following exercise (Karlsson et al., 2004; Blomstrand et 
al. 2006; Jackman et al. 2017), we hypothesized that BCAA supplementation would 
ameliorate the post-exercise negative symptoms (i.e., soreness and loss of muscle 
function) associated with RE stimulus. Contrary to our hypothesis, we found no 
evidence indicating that BCAA supplementation could alleviate the alterations of 
muscle soreness and function (i.e., number of repetitions, perceived exertion, jumping 
height, and PPO/BW) during time course of recovery from RE.  
 It has been postulated that the beneficial effects of BCAA are evident when 
exercise results in a low-to-moderate, but not severe muscle damage (Fouré et al. 2016; 
Fouré and Bendahan, 2017). For example, Aminiaghdam et al. (2012) and Fouré et al. 
(2016) found no beneficial effects of BCAA supplementation on markers of recovery 
(i.e., maximal voluntary isometric contraction, soreness, and concentrations of 
phosphocreatine [PCr], inorganic phosphate [Pi] and pH) in response to an exercise-
induced severe damage (peak CK levels ranged from 660 to 17211 IU/L), while other 
authors (Jackman et al. 2010; Shimomura et al. 2010; Howatson et al. 2012) showed an 
attenuation of muscle soreness when a low-to-moderate damage was achieved (peak CK 
levels ranged from 80 to 400 IU/L). However, our results do not support this 
supposition that the positive effects of BCAA are dependent on the level of muscle 
damage. Although we did not analyze CK levels in current study, previous findings 
from our laboratory (da Silva et al. 2017; Andrade et al. 2018) showed peak CK values 
around 300-350 IU/L using similar RE protocols. Therefore, even with a moderate 
 
 
exercise-induced muscle damage, BCAA supplementation failed to alleviate muscle 
soreness compared to the placebo group, suggesting that the relationship between 
BCAA supplementation and muscle damage is unwarranted.  
It is noteworthy that CK levels may be ambiguous for analyzing the impact of 
BCAA supplementation on muscle soreness, since a positive effect of BCAA was found 
on muscle soreness (Jackman et al. 2010; Waldron et al., 2017), even when CK levels 
were unchanged (Jackman et al. 2010, Shimomura et al. 2010) or higher (Waldron et al., 
2017) in relation placebo. Moreover, a large interindividual variability is often observed 
in CK levels in response to muscle damage (Clarkson and Ebbeling, 1988) and there is 
no correlation between the increase in CK and loss of muscle strength (Jackman et al. 
2010). These findings support the idea that CK levels might not be an appropriate 
indirect marker of muscle damage (Chrismas et al. 2013), and suggest that 
complementary markers (e.g., soreness and strength) should be used in the context of 
muscle recovery. Regardless of the limitations involving CK levels, our results indicate 
that BCAA supplementation is unable attenuate muscle soreness over the time course of 
recovery from RE, corroborating recent findings from a well-conducted meta-analysis 
study (Rahimi et al. 2017). 
 In addition to soreness, we observed no effect of BCAA supplementation on 
muscle function between the two RE sessions (i.e., number of repetitions and perceived 
exertion) and during the recovery period (i.e., jumping height and PPO/BW). Our 
results are consistent with previous studies that found a small-to-moderate (Waldron et 
al. 2017) or no beneficial effect of BCAA on muscle function (e.g., strength and power) 
during recovery from exercise (Jackman et al. 2010; Areces et al. 2014; Fouré et al. 
2016; Kephart et al. 2016). On the other hand, some studies have shown that BCAA 
supplementation may attenuate the decline of muscle strength after exercise (Greer et al. 
 
 
2007; Shimomura et al. 2010; Howatson et al. 2012; Gee and Daniel, 2016). The small 
amount of studies and wide discrepancy of results found in the literature regarding the 
extent of muscle damage (EMD) and positive effects of BCAA supplementation 
preclude a more in-depth discussion about our findings. For example, among the 4 
studies that found positive effects of BCAA on muscle function, 3 reported low EMD 
and 1 reported moderate EMD (according to criteria suggested by Fouré and Bendahan, 
2017); while among the 5 studies that found a small-to-moderate or no positive effect of 
BCAA, 2 reported low EMD and 2 high EMD and 1 moderate EMD. A likely 
explanation for this discrepancy in EMD may be the wide methodological variety (e.g., 
type of exercise, timing and period of supplementation, and studied sample) among 
studies. Therefore, this mix of discordant results indicate that relationship between 
EMD and positive effects of BCAA supplementation on muscle function during 
exercise recovery seems still unclear. Our results add for this assertion by showing that 
BCAA supplementation does not improve muscle function during recovery from a 
moderate EMD induced by RE.  
 The lack of effect of BCAA supplementation found in our study does not seem 
to be explained by the supplementation strategy (i.e., duration, frequency, and dosage), 
since most studies that found positive results used similar supplementation strategies 
(according to criteria suggested by Fouré and Bendahan, 2017) (duration: short [3 days 
or less] to long [more than 10 days], frequency: low [less than 2 intakes per day] to high 
[2 or more intakes per day], and dosage: low [< 200 mg/kg/d] to high [≥ 200 mg/kg/d]) 
(Greer et al. 2007; Shimomura et al. 2010; Howatson et al. 2012; Gee and Daniel, 2016) 
in comparison with our study and others with negative findings (duration: short [3 days 
or less] to moderate [between 4 and 10 days], frequency: low [less than 2 intakes per 
day] to high [2 or more intakes per day], and dosage: low [< 200 mg/kg/d] to high [≥ 
 
 
200 mg/kg/d]) (Waldron et al. 2017; Jackman et al. 2010; Areces et al. 2014; Fouré et 
al. 2016; Kephart et al. 2016).  It is important to note that among studies that found 
positive effects only one (Howatson et al. 2012) used a longer supplementation period 
(more than 10 days), while others (Greer et al. 2007; Shimomura et al. 2010; Gee and 
Daniel, 2016) used a shorter duration (3 days or less). Moreover, in two of these studies 
(Greer et al. 2007; Shimomura et al. 2010) the duration, frequency and dosage were 
short (1 day), low (<2x/day) and low (~5 g), respectively, suggesting that 
supplementation strategy was not the key factor for positive outcomes. Interestingly, in 
our study the duration (5 days) and dosage (8 g) was longer and the frequency (1x/day) 
similar compared to the studies of Greer et al. (2007) and Shimomura et al. (2010), 
reinforcing the notion that the interaction between BCAA supplementation and muscle 
recovery may be associated with other factors not related to the strategy of 
supplementation. Therefore, in the light of our findings and discrepancy among 
previous studies it seems premature to consider BCAA supplementation as a potential 
strategy to improve the muscle recovery from exercise.  
It is important to mention that an BCAA dose <8.0 g is sufficient to significantly 
increased plasma BCAA concentrations in humans (Shimomura et al., 2006; Fouré et al. 
201). Thus, the lack of a positive effect of BCAA supplementation on muscle recovery 
from RE does not necessarily indicate that our participants did not experience an 
increase in muscle BCAA levels. However, we cannot rule out the possibility that daily 
protein intake (~1.5 g/kg/d) might have been sufficient to maximize muscle recovery in 
our participants, masking the BCAA effects. The analysis of daily nutritional intake 
reinforces the internal validity of our study compared to previous studies in this area, 
since most studies that found positive effects of BCAA on muscle recovery markers did 
 
 
not analyze the participants' protein intake, precluding to determine whether the effects 
of BCAA supplementation were independent of the daily protein intake. 
A few limitations of this study must be mentioned. First, we did not analyze 
blood amino acids levels to confirm the absorption of BCCA. However, previous 
studies using lower doses have shown an increase in plasma BCAA concentration 
(Shimomura et al. 2010; Fouré et al. 2016). Second, we did not collect muscle biopsies 
for analysis of direct markers of muscle regeneration (e.g., IGF-I, mTOR, and p70S6 k); 
however, we analyzed the soreness levels and muscle power as tissue and functional 
markers of muscle recovery after exercise (Rindom et al. 2016). Finally, we decided to 
analyze the markers of muscle recovery only after the second exercise session to 
generate a cumulative effect of the mechanical/physiological stress between two 
sessions and thus mimic a practical resistance training routine; however, we cannot 
exclude the possibility that the effects of the first session may have somewhat 
influenced the response of the second session and thus the recovery process between 
groups.  
In conclusion, our data indicate that BCAA supplementation does not improve 
muscle soreness and function during recovery from RE in untrained young adults. These 
results bring into question the ergogenic potential of BCAA for improving muscle 
recovery in healthy individuals, and thereby suggest that other mechanisms may be 
involved in the muscle recovery in response to BCAA supplementation. Further studies 
are required to assess the effects of BCAA supplementation on muscle recovery in other 
populations (e.g., elderly and/or women), with different training status (e.g., recreational 
practitioners and/or athletes) and training protocols (e.g., whole-body muscle groups) to 
better understand the underlying mechanism(s) of this supplement before making any 
recommendation about its utilization as an ergogenic aid for recovery. 
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FIGURE LEGENDS 
 
Figure. 1. Experimental design.  
Figure. 2. Number of repetitions (A) and perceived exertion (B) over 3 sets of leg press 
exercise in the last training session in the BCAA (N = 12) and Placebo (N = 12) groups. 
Data are means ± SD. Difference letters indicate significant difference over time at P < 
0.05. 
Figure. 3. Muscle soreness during walking up (A) and walking down (B) a flight of 
stairs at baseline (pre-exercise) and during the recovery period (30 min., 24 h, and 48 h 
postexercise) in the BCAA (N = 12) and Placebo (N = 12) groups. Data are means ± SD. 
Difference letters indicate different from each other and compared to baseline at P < 
0.05. 
Figure. 4. Jumping weight (A) and peak power output/body weight (PPO/BW) (B) at 
baseline (pre-exercise) and during the recovery period (30 min., 24 h, and 48 h 
postexercise) in the BCAA (N = 12) and Placebo (N = 12) groups. Data are means ± SD. 
a P < 0.05 compared to basal, 24 h, and 48 h.  
 
 
 
 
